Journal for ImmunoTherapy of Cancer Issues Research Articles in August 2024 Edition
September 05, 2024
September 05, 2024
MILWAUKEE, Wisconsin, Sept. 5 -- The Journal for ImmunoTherapy of Cancer, a peer-reviewed journal from the Society for Immunotherapy of Cancer that says it features all aspects of tumor immunology and cancer immunotherapy, published research articles on the following topics in its August 2024 edition (Vol. 12, Issue 8):
Clinical/translational cancer immunotherapy
* Original research: Eganelisib combined with immune checkpoint inhibitor therapy and chemotherapy in frontl . . .
Clinical/translational cancer immunotherapy
* Original research: Eganelisib combined with immune checkpoint inhibitor therapy and chemotherapy in frontl . . .